The first one involves the activation of the Ulk1/Atg1 protein kinase complex that is inhibited by the mechanistic target of rapamycin (mTOR) and activated by AMP-activated protein kinase (AMPK) during nutrient deficiency. Here, MTOR is linked to hyperinsulinemic hypoglycemia, familial, 4.